-
ESMO 2023 | Professor Man Li: Dato-DXd Multidomain Efficacy Data Released, Bringing Hope for Survival to More Cancer Patients
Editor’s note: Currently, antibody-drug conjugates (ADCs) have become “star drugs” in the field of cancer treatment. Dato-DXd is a novel ADC that consists of a humanized monoclonal antibody targeting Trop-2,…
-
ESMO in 5 Minutes | Professor Man Li: Advances in Early Breast Cancer Treatment
Editor’s Note: The primary goal for early-stage breast cancer patients is cure, and numerous studies have explored treatment strategies based on this objective. In this edition of the ESMO conference,…
-
ESMO Hot Review | Dr. Lu Si and LiLi Mao: Addressing Challenges in the Treatment of Melanoma, Breaking Through the Difficulties of Brain Metastases
Editor’s Note: The 2023 European Society for Medical Oncology (ESMO) Annual Meeting took place in Madrid, Spain as scheduled. What new developments are there in the field of melanoma, which…
-
WCLC 2023 |Dr. Zhu Zhengfei: SBRT Combined with Dual Immune Checkpoint Inhibitors for Advanced NSCLC Achieves a Median OS of 34 Months
The 2023 World Conference on Lung Cancer (WCLC), organized by the International Association for the Study of Lung Cancer (IASLC), was held in Singapore from September 9th to 12th. ” Oncology Frontier” invited Zhu Zhengfei from Fudan University-affiliated Cancer Hospital to comment on the findings of the COSINR study.
-
The Value of Lepidic and Invasion Patterns New Diagnostic Criteria for the Differential Diagnosis of AIS, MIA from Invasive Adenocarcinoma
At the 2023 World Conference on Lung Cancer (WCLC), Dr. Xie Huikang from Shanghai Pulmonary Hospital presented a study titled ” The Value of Lepidic and Invasion Pattern NEW Diagnostic Criteria for the Differential Diagnosis of AIS, MIA from Invasive Adenocarcinoma .” The study aimed to explore whether the new IASLC definitions and standards had…
-
WCLC Voice of China | Dr. Liang Application of Video-Based Artificial Intelligence in Thoracoscopic Lobectomy for Lung Cancer
From September 9th to 12th, 2023, the World Conference on Lung Cancer (WCLC) was held in Singapore. Oncology Frontier deeply engaged in the conference, capturing the latest advancements and witnessing the progress and strides made by China in the international oncology arena. Dr. Liang Hengrui of the First Affiliated Hospital of Guangzhou Medical University presented…
-
WCLC 2023| Dr. Wang Jie Awarded the 2023 Small Cell Lung Cancer Heine H. Hansen Award
The International Association for the Study of Lung Cancer (IASLC) annually presents several awards to clinical physicians and researchers who have made significant contributions to the treatment of lung cancer patients. Awardees are invited to receive their awards at the World Conference on Lung Cancer (WCLC) and give speeches in their respective fields. At the…
-
WCLC 2023 | Dr. Han Baohui’s Team Presents Multiple Research Achievements, Making China’s Voice Resonate at WCLC
The 2023 World Conference on Lung Cancer (WCLC) was held at the Singapore Expo, attracted over 6,000 participants from various fields of basic and clinical science related to thoracic malignancies. The conference received approximately 1,800 abstracts, featured over 350 invited lectures, 150 oral presentations, mini-oral presentations, and more than 1,500 posters and electronic posters, showcased…
Connecting Medical Expertise through Media